My Quote Request
No products added yet
6505-01-470-1917
20 Products
0
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505014701917
NSN
6505-01-470-1917
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INFLUENZA VIRUS VAC USP TRIVALENT 00.01 SEASON 6MO/0.5ML 10S
SPECIAL FEATURES: TRIVALENT, CARTRIDGE-NEEDLE UNIT, 0.5 ML FILL IN 1 ML SIZE (25 GAUGEX5/8 INCH), 0.5ML DOSE, 1 DOSE, 10'S, SPLIT VIRUS; FOR 2000-2001 INFLUENZA SEASON; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE OR OLDER,
UNIT PACKAGE QUANTITY: 10
VALENCE: TRIVALENT
VIRUS STRAIN: 2000-2001 INFLUENZA
~1: REQUIRES REFRIGERATION BETWEEN 2-8 DEGREE C.; SUBJ TO DAMAGE BY FREEZING
Related Searches:
0
METRONIDAZOLE INJECTION,USP
NSN, MFG P/N
6505014626450
NSN
6505-01-462-6450
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METRONIDAZOLE INJECTION 100ML BAG 24S
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG
SPECIAL FEATURES: 100 ML, BAG, 24'S
Related Searches:
0
FAT EMULSION INJECTION
NSN, MFG P/N
6505014626514
NSN
6505-01-462-6514
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAT EMULSION INJECTION 10% 500ML GLASS BT 10S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: 10%, 500 ML, GLASS BOTTLE, 10'S
Related Searches:
0
FAT EMULSION INJECTION
NSN, MFG P/N
6505014626516
NSN
6505-01-462-6516
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: FAT EMULSION INJECTION 20% 500ML GLASS BT 10S
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE, GLASS
SPECIAL FEATURES: 20%, 500 ML, GLASS BOTTLE, 10'S
Related Searches:
0
LYME DISEASE VACCIN
NSN, MFG P/N
6505014626643
NSN
6505-01-462-6643
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: LYME DISEASE VACCINE RECOMBINANT OSPA 30 MCG/0.5 ML, SINGLE-DOSE VIAL; 10'S; DO
PART NAME ASSIGNED BY CONTROLLING AGENCY: LYMERIX
~1: NOT FREEZE; REQUIRES REFRIG BTWN 2-8 DEG C
Related Searches:
0
LYME DISEASE VACCIN
NSN, MFG P/N
6505014626648
NSN
6505-01-462-6648
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: LYME DISEASE VACCINE RECOMBINANT OSPA 30 MCG/0.5 ML; SYRINGE NEEDLE UNIT, 5'S; D
PART NAME ASSIGNED BY CONTROLLING AGENCY: LYMERIX
~1: O NOT FREEZE; REQUIRES REFRIG BTWN 2-8 DEG C
Related Searches:
0
SUMATRIPTAN TABLETS
NSN, MFG P/N
6505014629906
NSN
6505-01-462-9906
Description
PART NAME ASSIGNED BY CONTROLLING AGENCY: SUMATRIPTAN TABLETS 25MG 9S PG
SPECIAL FEATURES: SUMATRIPTAN TABLETS; 25 MG, 9'S
Related Searches:
0
DIAZEPAM INJECTION,
NSN, MFG P/N
6505014658720
NSN
6505-01-465-8720
Description
SPECIAL FEATURES: 5MG/ML;2 ML(10MG); CARTRIDGE NEEDLE UNIT; FOR USE WITH TUBEX INJECTOR; 10'S; CLASS 4; CONTROLLED SUBSTANCE SCHEDULE IV; CIIC Q
Related Searches:
0
EPHEDRINE SULFATE INJECTION,USP
NSN, MFG P/N
6505014665292
NSN
6505-01-466-5292
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: EPHEDRINE SULFATE INJECTION USP 50MG/ML 1ML 25S
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: ANY ACCEPTABLE
SPECIAL FEATURES: 50 MG/ML; 1 ML; 25'S
Related Searches:
0
AMMONIA INHALANT PA
NSN, MFG P/N
6505014665295
NSN
6505-01-466-5295
Description
GENERAL CHARACTERISTICS ITEM DESCRIPTION: AMMONIA INHALANT PADS, 15% AMMONIA IN A 20% ISOPROPYL ALCOHOL; 1,000 PACKETS PER PKG
III PART NAME ASSIGNED BY CONTROLLING AGENCY: AMMONIA INHALANT PADS 1000S
Related Searches:
0
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014667167
NSN
6505-01-466-7167
0
SUCCINYLCHOLINE CHLORIDE INJECTION,USP
NSN, MFG P/N
6505014667167
NSN
6505-01-466-7167
Description
(NON-CORE DATA) UNIT PACKAGE TYPE: PACKAGE
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS SUCCINYLCHOLINE CHLORIDE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SUCCINYLCHOLINE CHLORIDE INJECTION USP 20MG/ML 10ML VIAL 12S
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
0
CERIVASTATIN SODIUM TABLETS
NSN, MFG P/N
6505014695504
NSN
6505-01-469-5504
Description
PART NAME ASSIGNED BY CONTROLLING AGENCY: BAYCOL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 0.3 MG TABLETS, BOTTLE OF 100; A PRECURSOR OF CHOLESTEROL; END RESULT IS A REDUC
~1: TION IN PLASMA CHOLESTEROL CONCENTRATION
Related Searches:
0
CERIVASTATIN SODIUM TABLETS
NSN, MFG P/N
6505014695505
NSN
6505-01-469-5505
Description
PART NAME ASSIGNED BY CONTROLLING AGENCY: CERIVASTATIN TABLETS 0.2MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 0.2 MG TABLETS; BOTTLES OF 100; A PRECURSOR OF CHOLESTEROL; END RESULT IS A REDUCTION IN PLASMA CHOLESTEROL CONCENTRATION
Related Searches:
0
CERIVASTATIN SODIUM TABLETS
NSN, MFG P/N
6505014695506
NSN
6505-01-469-5506
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CERIVASTATIN TABLETS 0.4MG 30S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 0.4 MG TABLETS, BOTTLE OF 30; A PRECURSER OF CHOLESTEROL; END RESULT IS A REDUCTION IN PLASMA CHOLESTEROL CONCENTRATION
Related Searches:
0
TEST KIT,LEGIONELLA IDENTIFICATION
NSN, MFG P/N
6505014695524
NSN
6505-01-469-5524
Description
TEST KIT,LEGIONELLA IDENTIFICATION
Related Searches:
0
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014696084
NSN
6505-01-469-6084
0
HEPATITIS B VIRUS VACCINE,INACTIVATED,MODIFIED
NSN, MFG P/N
6505014696084
NSN
6505-01-469-6084
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: HEPATITIS B VIRUS VACCINE INACTIVATED MODIFIED
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION BETWEEN 2 DEG TO 8 DEG C AND SUBJECT TO DAMAGE BY FREEZING
IMMEDIATE CONTAINER TYPE: VIAL, SINGLE DOSE
QUANTITY WITHIN EACH IMMEDIATE CONTAINER: 0.5 ML
SPECIAL FEATURES: RECOMBINANT; PROVIDES 5 MICROGRAMS OF HEPATITIS B SURFACE ANTIGEN PER 0.5 ML; FOR INTRAMUSCULAR INJECTION VACCINE, MAY CONTAIN NOT MORE THAN 1% YEAST PROTEIN, FREE OF ASSOCIATION WITH HUMAN BLOOD OR BLOOD PRODUCTS, TESTED FOR STERILITY, PRESERVATIVE FREE
~1: (THIMEROSAL FREE), PEDIATRIC/ADOLESCENT FORMULATION FOR 0-19 YEARS OF AGE, SUPPLIED AS 5 MCG/0.5 ML OF HBSAG IN A 0.5 ML SINGLE DOSE VIAL
Related Searches:
0
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505014701725
NSN
6505-01-470-1725
Description
SPECIAL FEATURES: TRIVALENT, SYRINGE-NEEDLE UNIT, 0.5 ML DOSE, 1 DOSE, 10'S, SPLIT VIRUS 2000-2001
UNIT PACKAGE QUANTITY: 10
VALENCE: TRIVALENT
VIRUS STRAIN: 2000-2001 INFLUENZA
~1: INFLUENZA SEASON; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZ
~2: ING PERSONS 6 MONTHS OF AGE OR OLDER, REQUIRES REFRIGERATION BETWEEN 2-8 DEGREE
~3: C.; SUBJ TO DAMAGE BY FREEZING
Related Searches:
0
INFLUENZA VIRUS VACCINE,USP
NSN, MFG P/N
6505014701763
NSN
6505-01-470-1763
Description
SPECIAL FEATURES: TRAVALENT, VIAL; 0.5 ML DOSE, 10 DOSES; SPLIT VIRUS; FOR 2000-2001 INFLUENZA SEA
UNIT PACKAGE QUANTITY: 10
VALENCE: TRIVALENT
VIRUS STRAIN: 2000-2001 INFLUENZA
~1: SON; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6
~2: MONTHS OF AGE OR OLDER, REQUIRES REFRIGERATION BETWEEN 2-8 DEGREE C.; SUBJ TO DA
~3: MAGE BY FREEZING
Related Searches:
0
n/a
NSN, MFG P/N
6505014703082
NSN
6505-01-470-3082
Description
SPECIAL FEATURES: CARTRIDGE-NEEDLE UNIT; 0.5 ML FILL IN 1 ML SIZE (25 GAUGE X 5/8 IN.) 0.5 ML DOSE; SPLIT VIRUS; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTRATION; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE OR OLDER; REQUIRES REFRIGERATION BETWEEN 2-8 DEGREE C; SUBJECT TO
UNIT PACKAGE QUANTITY: 10
VALENCE: TRIVALENT
VIRUS STRAIN: 2000-2001 INFLUENZA
~1: DAMAGE BY FREEZING
Related Searches:
0
n/a
NSN, MFG P/N
6505014703113
NSN
6505-01-470-3113
Description
SPECIAL FEATURES: 0.5 ML DOSE; SPLIT VIRUS; FOR SUBCUTANEOUS OR INTRAMUSCULAR ADMINISTATION; FOR IMMUNIZING PERSONS 6 MONTHS OF AGE OR OLDER; REQUIRES REFRIGERATION BETWEEN 2-8 DEGREE C; SUBJECT TO DAMAGE BY FREEZING
UNIT PACKAGE QUANTITY: 10
VALENCE: TRIVALENT
VIRUS STRAIN: 2000-2001 INFLUENZA
